AAAAAA
Results:
1-16
|
Results: 16
Authors:
Burman, WJ
Gallicano, K
Peloquin, C
Citation: Wj. Burman et al., Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials, CLIN PHARMA, 40(5), 2001, pp. 327-341
Authors:
Khaliq, Y
Gallicano, K
Tisdale, C
Carignan, G
Cooper, C
McCarthy, A
Citation: Y. Khaliq et al., Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers, BR J CL PH, 51(6), 2001, pp. 591-600
Authors:
Angel, JB
Khaliq, Y
Monpetit, ML
Cameron, DW
Gallicano, K
Citation: Jb. Angel et al., An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancy, AIDS, 15(3), 2001, pp. 417-419
Authors:
Gallicano, K
Khaliq, Y
Carignan, G
Tseng, A
Walmsley, S
Cameron, DW
Citation: K. Gallicano et al., A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus, CLIN PHARM, 70(2), 2001, pp. 149-158
Authors:
Murri, R
Ammassari, A
Gallicano, K
De Luca, A
Cingolani, A
Jacobson, D
Wu, AW
Antinori, A
Citation: R. Murri et al., Patient-reported nonadherence to HAART is related to protease inhibitor levels, J ACQ IMM D, 24(2), 2000, pp. 123-128
Authors:
Phenix, BN
Angel, JB
Mandy, F
Kravcik, S
Parato, K
Chambers, KA
Gallicano, K
Hawley-Foss, N
Cassol, S
Cameron, DW
Badley, AD
Citation: Bn. Phenix et al., Decreased HIV-associated T cell apoptosis by HIV protease inhibitors, AIDS RES H, 16(6), 2000, pp. 559-567
Authors:
Khaliq, Y
Gallicano, K
Seguin, I
Fyke, K
Carignan, G
Bulman, D
Badley, A
Cameron, DW
Citation: Y. Khaliq et al., Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease, BR J CL PH, 50(2), 2000, pp. 108-115
Authors:
Khaliq, Y
Gallicano, K
Leger, R
Foster, B
Badley, A
Citation: Y. Khaliq et al., A drug interaction between fusidic acid and a combination of ritonavir andsaquinavir, BR J CL PH, 50(1), 2000, pp. 82-83
Authors:
Brooks, JI
Gallicano, K
Garber, G
Angel, JB
Citation: Ji. Brooks et al., Acute monoarthritis complicating therapy with indinavir, AIDS, 14(13), 2000, pp. 2064-2065
Authors:
Gallicano, K
Citation: K. Gallicano, Antiretroviral-drug concentrations in semen, ANTIM AG CH, 44(4), 2000, pp. 1117-1117
Authors:
Khaliq, Y
Gallicano, K
Venance, S
Kravcik, S
Cameron, DW
Citation: Y. Khaliq et al., Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus, CLIN PHARM, 68(6), 2000, pp. 637-646
Authors:
Khaliq, Y
Gallicano, K
Sahai, J
Citation: Y. Khaliq et al., Introduction to drug interactions, INFEC DIS S, 2000, pp. 1-11
Authors:
Nix, D
Gallicano, K
Citation: D. Nix et K. Gallicano, Design and data analysis in drug interaction studies, INFEC DIS S, 2000, pp. 333-351
Authors:
Kravcik, S
Gallicano, K
Roth, V
Cassol, S
Hawley-Foss, N
Badley, A
Cameron, DW
Citation: S. Kravcik et al., Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir andsaquinavir, J ACQ IMM D, 21(5), 1999, pp. 371-375
Authors:
Burman, WJ
Gallicano, K
Peloquin, C
Citation: Wj. Burman et al., Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis, CLIN INF D, 28(3), 1999, pp. 419-429
Authors:
McGilveray, IJ
Gallicano, K
Citation: Ij. Mcgilveray et K. Gallicano, Generic drugs: The Canadian perspective, TRANSPLAN P, 31(3A), 1999, pp. 16S-18S
Risultati:
1-16
|